2023 Editorial Calendar

Content themes:

• Bio/Pharma’s Top 10: Monthly tracker of the top 10 trends, deals, and developments impacting global bio/pharmaceutical industry performance and the global bio/pharmaceutical manufacturing value chain.
• The CDMO/CMO and Suppliers Report: The keys developments from CDMOs/CMOs and suppliers and trends shaping bio/pharmaceutical outsourcing and supply.
• Executive One-on-One:  In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
• Manufacturing and Supply Lines: The latest from the bio/pharmaceutical manufacturing value chain, from raw materials to active pharmaceutical ingredients (small molecules and biologics) to drug products to packaging.
• Special Reports: Special coverage of DCAT webinars and education programs, including programs from DCAT Week as well as other industry-focused reports.

DCAT Value Chain Insights 2022 Editorial Calendar: January-December 2022

January 6	Bio/Pharma’s Top 10: An Industry Watchlist for 2023 The top 10 issues to be on the look for in 2023.
January 13	CDMO/CMO and Suppliers Report: The Year Ahead in Pharma Outsourcing An outlook for bio/pharmaceutical outsourcing for 2023.
January 20	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
January 27	Manufacturing and Supply Lines: The Impact Factors for 2023 Industry experts provide perspective on what they see as the key issues impacting bio/pharma manufacturing and supply in 2023.

February 3	Bio/Pharma’s Top 10: Small Molecules & Biologics Top 10 trends in new drug approvals, including the mix between small molecules and biologics.
February 10	The CDMO/CMO and Suppliers Report: API Sourcing Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates.
February 17	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
February 24	Special Report: DCAT Week 2023 Preview Special preview of upcoming speakers and education programs at DCAT Week 2022 (March 20 to March 23, 2023).

March 3	Special Report: DCAT Week 2023 Preview Special preview of upcoming speakers and education programs at DCAT Week 2022 (March 20 to March 23, 2023).
March 10	The CDMO/CMO and Suppliers Report: Cell & Gene Therapies Update of key expansions from CDMOs/CMOs for manufacturing of cell and gene therapies.
March 17	No issue DCAT Week 2023 (March 20 to March 23, 2023).
March 24	No issue DCAT Week 2023 (March 20 to March 23, 2023).
March 31	Special Report: DCAT Week 2023 in Review Detailed roundup from the DCAT Member Company Announcement Forum and the DCAT Research & Benchmarking Study as presented at DCAT Week 2023.

April 7	Special Report: DCAT Week 2023 in Review Roundup from the education programs at DCAT Week 2023, including a bio/pharmaceutical industry outlook.
April 14	The CDMO/CMO and Suppliers Report: Parenteral Drugs Update of key expansions from CDMOs/CMOs in parenteral drug development and manufacturing.
April 21	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
April 28	Manufacturing and Supply Lines: Small-Molecule APIs Market overview for small-molecule active pharmaceutical ingredients (APIs) and supply–demand fundamentals.

May 5	Bio/Pharma’s Top 10: Blockbuster Watchlist A look at the top 10 drugs slated for launch in 2023 with blockbuster potential over the next five years.
May 12	The CDMO/CMO and Suppliers Report: Biomanufacturing Expansions and technology updates in upstream and downstream bioprocessing.
May 19	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
May 26	No issue

June 2	Bio/Pharma’s Top 10: Top Deals Thus Far in 2023 Analysis of top 10 mergers and acquisitions and partnering deals among bio/pharma companies thus far in 2023.
June 9	The CDMO/CMO and Suppliers Report: What’s Trending in Pharma Outsourcing The key trends and developments in the CDMO/CMO sector.
June 16	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
June 23	Manufacturing and Supply Lines: Inside Big Pharma’s Manufacturing Networks The latest manufacturing expansion activity among the bio/pharmaceutical majors.
June 30	Special Report: Generic Drugs Market outlook and analysis of key developments in the generic-drug industry.

July 7	No issue
July 14	The CDMO/CMO and Suppliers Report High-Potency APIs Update on expansions by CDMOs/CMOs for high-potency active pharmaceutical ingredients (HPAPI) manufacturing and related trends.
July 21	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
July 28	Manufacturing and Supply Lines: Injectable Drugs Industry experts provide insight on key trends and technological developments for injectable drugs, including drug-device technology.

August 4	Bio/Pharma’s Top 10: Emerging Pharma Top 10 Emerging Pharma companies gaining interest from investors and larger pharma companies in partnering deals.
August 11	The CDMO/CMO and Suppliers Report: Packaging Industry overview of key trends and developments in primary and secondary packaging.
August 18	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
August 25	No issue

September 1	Bio/Pharma’s Top 10: Biologics The top 10-selling biologics and pipeline contenders.
September 8	The CDMO/CMO and Suppliers Report: Formulation Development and Drug Products Latest market and technological advances for solid-dosage and parenteral drugs.
September 15	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
September 22	Manufacturing and Supply Lines: Small-Molecule APIs Analysis of key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates.
September 29	Special Report: India Analysis of import and export data for active pharmaceutical ingredients and drug products in India.

October 6	Bio/Pharma’s Top 10: Small Molecules The top 10-selling biologics and pipeline contenders.
October 13	The CDMO/CMO and Suppliers Report: Biomanufacturing A roundup of key expansions by CDMOs/CMOs in biomanufacturing.
October 20	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
October 27	Manufacturing and Supply Lines: Continuous Manufacturing Update of key projects, investments, and advances in continuous manufacturing for both active pharmaceutical ingredients and drug products.

November 3	Bio/Pharma’s Top 10: The Pipeline Contenders Top 10 late-stage drug candidates with strong market potential.
November 10	The CDMO/CMO and Suppliers Report: High-Potency Drug Products A roundup of expansions of CDMOs/CMOs in high-potency drug-product manufacturing.
November 17	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.
November 24	No issue Thanksgiving Holiday.

December 1	Bio/Pharma’s Top 10: The Year in Review A look at the top 10 developments in the bio/pharma industry in 2023.
December 8	The CDMO/CMO and Suppliers Report: The Movers and Shakers of 2023 A look at the top expansions and mergers/acquisitions from CDMOs/CMOs in 2023.
December 15	Executive One-on-One In-depth interviews on key industry trends and strategic insights featuring senior executives heading manufacturing, supply, procurement and operations.

There are no issues December 22 and December 29.